Vision loss is something that can come in many different forms due to the process of aging. However, one specific form of central-vision loss known as dry macular degeneration can pose serious problems if not given proper attention.
Dr. Richard Breazeale“Dry macular degeneration (AMD) is an aging change that causes tissue under the retina to disappear slowly,” explained Dr. Richard Breazeale, M.D., with Southeastern Retina Associates. “This causes the central retina
to work poorly, eventually leading to central-vision loss.”
There is currently no treatment available for the condition. However, investigative studies are being done on certain
types of AMD.
“We at Southeastern Retina Associates in Chattanooga have been chosen as a site for a clinical trial being run at
select centers worldwide to evaluate the effectiveness of a new medicine on slowing the progression of geographic atrophy, which is a type of dry macular degeneration,” said Dr. Breazeale.
The ongoing damage to the retina takes time, which is why AMD is recognized as age-related, according to Dr.
Breazeale. Patient genetics can also come into play.
Patients with geographic atrophy and visual acuity of 20/100 or better are ideal candidates for this new study available at Southeastern Retina Associates.
For those not participating in the study, there are some key preventive measures to be taken, including not smoking cigarettes, paying attention to diet and maintaining a regular exercise routine.